Literature DB >> 23961993

Regulation of the transcriptional activation of the androgen receptor by the UXT-binding protein VHL.

Shuliang Chen1, Ke Chen, Qinghua Zhang, Hanhua Cheng, Rongjia Zhou.   

Abstract

Loss and/or inactivation of the VHL (von Hippel-Lindau) tumour suppressor causes various tumours. Using a yeast two-hybrid system, we have identified the AR (androgen receptor) co-activator UXT (ubiquitously expressed transcript), as a VHL-interacting protein. GST pull-down and co-immunoprecipitation assays show that UXT interacts with VHL. In addition, UXT recruits VHL to the nucleus. VHL associates with the DBD (DNA-binding domain) and hinge domains of the AR and induces AR ubiquitination. Moreover, VHL interaction with the AR activates AR transactivation upon DHT (dihydrotestosterone) treatment. VHL knockdown inhibits AR ubiquitination and decreases transcriptional activation of the AR. Our data suggest that the VHL-UXT interaction and VHL-induced ubiquitination of AR regulate transcriptional activation of the AR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23961993     DOI: 10.1042/BJ20121711

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  10 in total

1.  UXT-AS1-induced alternative splicing of UXT is associated with tumor progression in colorectal cancer.

Authors:  Jun Yin; Wei Luo; Xiang Zeng; Lisi Zeng; Zhiyang Li; Xiaofang Deng; Xiaojun Tan; Weimin Hu
Journal:  Am J Cancer Res       Date:  2017-03-01       Impact factor: 6.166

Review 2.  Functional roles of E3 ubiquitin ligases in prostate cancer.

Authors:  Yiting Zhao; Jinyun Li; Jun Chen; Meng Ye; Xiaofeng Jin
Journal:  J Mol Med (Berl)       Date:  2022-07-11       Impact factor: 5.606

3.  Ubiquitously expressed transcript is a novel interacting protein of protein inhibitor of activated signal transducer and activator of transcription 2.

Authors:  Xiang Kong; Shikun Ma; Jiaqian Guo; Yan Ma; Yanqiu Hu; Jianjun Wang; Ying Zheng
Journal:  Mol Med Rep       Date:  2014-12-01       Impact factor: 2.952

4.  ZBRK1, a novel tumor suppressor, activates VHL gene transcription through formation of a complex with VHL and p300 in renal cancer.

Authors:  Ke Chen; Gan Yu; Kiranmai Gumireddy; Anping Li; Weimin Yao; Lu Gao; Shuliang Chen; Jun Hao; Ji Wang; Qihong Huang; Hua Xu; Zhangqun Ye
Journal:  Oncotarget       Date:  2015-03-30

5.  The histone demethylase KDM3A regulates the transcriptional program of the androgen receptor in prostate cancer cells.

Authors:  Stephen Wilson; Lingling Fan; Natasha Sahgal; Jianfei Qi; Fabian V Filipp
Journal:  Oncotarget       Date:  2017-05-02

6.  Ubiquitous expressed transcript promotes tumorigenesis by acting as a positive modulator of the polycomb repressive complex 2 in clear cell renal cell carcinoma.

Authors:  Jin Zeng; Wei Xiang; Yucong Zhang; Chunhua Huang; Ke Chen; Zhiqiang Chen
Journal:  BMC Cancer       Date:  2019-09-03       Impact factor: 4.430

7.  VHL negatively regulates SARS coronavirus replication by modulating nsp16 ubiquitination and stability.

Authors:  Xiao Yu; Shuliang Chen; Panpan Hou; Min Wang; Yu Chen; Deyin Guo
Journal:  Biochem Biophys Res Commun       Date:  2015-02-28       Impact factor: 3.575

8.  The pVHL neglected functions, a tale of hypoxia-dependent and -independent regulations in cancer.

Authors:  Giovanni Minervini; Maria Pennuto; Silvio C E Tosatto
Journal:  Open Biol       Date:  2020-07-01       Impact factor: 6.411

9.  UXT chaperone prevents proteotoxicity by acting as an autophagy adaptor for p62-dependent aggrephagy.

Authors:  Min Ji Yoon; Boyoon Choi; Eun Jin Kim; Jiyeon Ohk; Chansik Yang; Yeon-Gil Choi; Jinyoung Lee; Chanhee Kang; Hyun Kyu Song; Yoon Ki Kim; Jae-Sung Woo; Yongcheol Cho; Eui-Ju Choi; Hosung Jung; Chungho Kim
Journal:  Nat Commun       Date:  2021-03-29       Impact factor: 14.919

Review 10.  Nuclear functions of prefoldin.

Authors:  Gonzalo Millán-Zambrano; Sebastián Chávez
Journal:  Open Biol       Date:  2014-07       Impact factor: 6.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.